Trevena, Inc. (NASDAQ:TRVN – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.01 and traded as high as $0.02. Trevena shares last traded at $0.02, with a volume of 2,369 shares.
Trevena Stock Performance
The stock has a market cap of $19,180.00, a price-to-earnings ratio of 0.00 and a beta of 0.59. The company’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.02.
Trevena Company Profile
Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.
The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.
Featured Stories
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
